What are the main export markets?

Main markets include North America, South America, Eastern Europe, Southeast Asia, Africa, Oceania, Mid East, and Western Europe.

Is customization available for production?

Yes, production is done in customized batches to meet rigorous specifications.

Boc-Thr (Me) CAS 48068-25-3 Fine Chemical

Name: Boc-Thr (Me) CAS 48068-25-3 Fine Chemical
Brand: Puyer Biopharma Ltd.
SKU: 2150393835

Jiangsu, ChinaPuyer Biopharma Ltd.

US$1.00-10.00

1 Piece

Sample price:US$50.00/piece.Request sample

Product profile

Customization

Available

CAS No.

48068-25-3

Formula

N/a

Model NO.

Fine Chemical

EINECS

N/a

Type

Synthesis Material Intermediates

Appearance

Powder

Quality

Industrial

Colour

White

Transport Package

Drum

Specification

99%

Trademark

PUYER

Origin

China

Production Capacity

100000kg/Month

Key features

High Purity Fine Chemical: Ensures high purity levels and specific molecular structures for complex synthesis.

Wide Industry Application: Used in pharmaceuticals, agrochemicals, electronics, cosmetics, and construction.

Customized Batch Production: Production in customized batches to meet rigorous specifications.

Strict Quality Control: Adherence to customer and regulatory standards throughout the process.

Industrial Grade Quality: White powder appearance suitable for industrial synthesis material intermediates.

Global Market Reach: Exports to North America, Europe, Asia, Africa, and Oceania.

Flexible Payment Terms: Supports LC, T/T, PayPal, Western Union, and other methods.

Fast Lead Time: Off-season lead time within 15 workdays; peak season one month.

Company profile

Puyer Biopharma Ltd.

Jiangsu, China

Business Type: Manufacturer/Factory, Trading Company, OtherExport Year: 2016-08-01Nearest Port: shanghai, qingdao, tianjinAverage Response Time: ≤10.66hTerms of Payment: LC, T/T, D/P, etc.International Commercial Terms(Incoterms): FOB, CFR, CIF, DAT, FAS, DDP, DAP, CIP, CPT, FCA, EXW

AI-Powered supplier vetting

SummaryPuyer Biopharma Ltd. is identified as a China-based limited company operating from Nantong, Jiangsu, with manufacturer/factory and trading-company classifications. Its stated scope covers APIs, intermediates, fine chemicals, nutraceuticals, crop science, animal health, and related services. Evidence indicates ISO 9001 certification, 21–30 years of combined R&D engineer experience, 6–10 quality-control staff, 10 production lines, batch production of more than 300 products, and multiple production or testing locations. The supplier exports independently, began exporting in 2016, and reports broad international market coverage. However, the provided information does not establish after-sales service processes, financial credibility, customization execution, or named customer cases. Indexes 8 and 9 identify a different entity, Tieling Municipal People’s Government, and are excluded from supplier conclusions.

Supplier typeThe supplier is described as a factory, manufacturer, and trading company. Puyer Biopharma Ltd. is a China-based limited company located in Nantong, Jiangsu, and its stated business covers production, R&D, and sales of pharmaceutical, chemical, nutrition, agricultural, and related products.

CertificationsThe supplier explicitly reports ISO 9001 certification for its management system. This provides direct evidence of a recognized quality-management certification, although no additional certifications are stated.

R&D capabilityPuyer is described as a high-tech enterprise founded by doctors and specializing in R&D, with 21–30 years of R&D engineer experience. It reports laboratories, testing centers, production bases, and investment in R&D testing and production equipment, directly supporting substantial innovation and technical-development capability.

Production capacityThe supplier reports 10 production lines, batch production of more than 300 products, multiple production bases, and stated annual capacities for salicylic acid, potassium humate, amino acid powder, dicalcium phosphate, and choline chloride. These figures provide explicit evidence of broad and sizable production capability.